Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
107,138,464
-
Share change
-
-1,352,129
-
Total reported value
-
$648,459,428
-
Put/Call ratio
-
96%
-
Price per share
-
$6.06
-
Number of holders
-
145
-
Value change
-
-$1,476,656
-
Number of buys
-
59
-
Number of sells
-
66
Institutional Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q4 2014
As of 31 Dec 2014 OREXIGEN THERAPEUTICS INC - COM (OREX) had 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 107,138,464 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital Research Global Investors, SAMLYN CAPITAL, LLC, BlackRock Fund Advisors, State Street Corp, Foresite Capital Management II, LLC, NEA Management Company, LLC, VANGUARD GROUP INC, and FRANKLIN RESOURCES INC.
This table shows 145 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.